162 related articles for article (PubMed ID: 34805634)
1. Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD.
Demoulin N; Nicola V; Michoux N; Gillion V; Ho TA; Clerckx C; Pirson Y; Annet L
Kidney Int Rep; 2021 Nov; 6(11):2821-2829. PubMed ID: 34805634
[TBL] [Abstract][Full Text] [Related]
2. Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
Spithoven EM; van Gastel MD; Messchendorp AL; Casteleijn NF; Drenth JP; Gaillard CA; de Fijter JW; Meijer E; Peters DJ; Kappert P; Renken RJ; Visser FW; Wetzels JF; Zietse R; Gansevoort RT; ;
Am J Kidney Dis; 2015 Nov; 66(5):792-801. PubMed ID: 26235803
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
[TBL] [Abstract][Full Text] [Related]
4. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
[TBL] [Abstract][Full Text] [Related]
5. Accuracy, Reproducibility and User Experience With Standardized Instructions for Measurement of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease.
Bevilacqua M; Hague CJ; Romann A; Levin A
Can Assoc Radiol J; 2023 May; 74(2):343-350. PubMed ID: 36063401
[TBL] [Abstract][Full Text] [Related]
6. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
[TBL] [Abstract][Full Text] [Related]
7. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
[TBL] [Abstract][Full Text] [Related]
9. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
[TBL] [Abstract][Full Text] [Related]
10. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose.
Bevilacqua MU; Hague CJ; Romann A; Sheitt H; Vasilescu DM; Yi TW; Levin A
Radiology; 2019 Jun; 291(3):660-667. PubMed ID: 30964424
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
[TBL] [Abstract][Full Text] [Related]
12. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
Sharma K; Caroli A; Quach LV; Petzold K; Bozzetto M; Serra AL; Remuzzi G; Remuzzi A
PLoS One; 2017; 12(5):e0178488. PubMed ID: 28558028
[TBL] [Abstract][Full Text] [Related]
13. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
14. Kidney volume and function in autosomal dominant polycystic kidney disease.
Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
[TBL] [Abstract][Full Text] [Related]
15. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
[TBL] [Abstract][Full Text] [Related]
16. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
[TBL] [Abstract][Full Text] [Related]
18. Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
Higashihara E; Torres VE; Chapman AB; Grantham JJ; Bae K; Watnick TJ; Horie S; Nutahara K; Ouyang J; Krasa HB; Czerwiec FS;
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2499-507. PubMed ID: 21903984
[TBL] [Abstract][Full Text] [Related]
19. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
20. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
Nakajima A; Lu Y; Kawano H; Horie S; Muto S
Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
